Suchergebnisse - "Xu, Weidong"

PubPharm (9)

1

Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer : a meta-analysis

enthalten in: European radiology | 2023

von Ma, J. | Yang, Q. | Ye, X. | +19

CommentIn: Eur Radiol. 2024 Jan 2;:. - PMID 38165433

2

Super-veil nerve-sparing extraperitoneal pure single-port robotic-assisted radical prostatectomy on da Vinci Si robotic system

enthalten in: World journal of urology | 2022

von Chang, Y. | Xu, W. | Xiao, Y. | +3

3

Super-veil nerve-sparing extraperitoneal pure single-port robotic-assisted radical prostatectomy on da Vinci Si robotic system

enthalten in: World journal of urology | 2022

von Chang, Y. | Xu, W. | Xiao, Y. | +3

4

Robotic Perineal Radical Prostatectomy : Initial Experience with the da Vinci Si Robotic System

enthalten in: Urologia internationalis | 2020

von Chang, Y. | Xu, W. | Lu, X. | +5

5

The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor

enthalten in: Urologic oncology | 2013

von Cui, Z. | Ren, S. | Lu, J. | +9

6

Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2013

von Ren, S. | Wang, F. | Shen, J. | +12

7

Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer

enthalten in: Journal of molecular medicine | 2012

von Ren, S. | Xu, C. | Cui, Z. | +10

8

Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer

enthalten in: Journal of molecular medicine | 2012

von Ren, S. | Xu, C. | Cui, Z. | +10

9

Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer

enthalten in: Journal of molecular medicine | 2012

von Ren, S. | Xu, C. | Cui, Z. | +10

1
[1]